In a doxorubicin-resistant hepatocellular carcinoma cell line, R-HepG2, it was found that knockdown of H19 resulted in an increase of promoter methylation at the MDR1 promoter. The gene discussed is ABCB1; the disease is hepatocellular carcinoma.